These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 27272836)
1. Expression of DOG1 (Using SP31) in Poorly Differentiated Carcinoma of the Head and Neck. Friedrich RE; Wunder T; Schumacher U; Bartel-Friedrich S; Zustin J Anticancer Res; 2016 Jun; 36(6):3117-22. PubMed ID: 27272836 [TBL] [Abstract][Full Text] [Related]
2. Expression of podoplanin in primary and metastatic poorly differentiated and undifferentiated carcinomas of the head and neck. Friedrich RE; Bartel-Friedrich S; Hagel C Anticancer Res; 2012 May; 32(5):2019-22. PubMed ID: 22593482 [TBL] [Abstract][Full Text] [Related]
3. Enhanced expression of ANO1 in head and neck squamous cell carcinoma causes cell migration and correlates with poor prognosis. Ruiz C; Martins JR; Rudin F; Schneider S; Dietsche T; Fischer CA; Tornillo L; Terracciano LM; Schreiber R; Bubendorf L; Kunzelmann K PLoS One; 2012; 7(8):e43265. PubMed ID: 22912841 [TBL] [Abstract][Full Text] [Related]
4. DOG1: a novel marker of salivary acinar and intercalated duct differentiation. Chênevert J; Duvvuri U; Chiosea S; Dacic S; Cieply K; Kim J; Shiwarski D; Seethala RR Mod Pathol; 2012 Jul; 25(7):919-29. PubMed ID: 22460810 [TBL] [Abstract][Full Text] [Related]
5. The EGF receptor system in head and neck carcinomas and normal tissues. Immunohistochemical and quantitative studies. Christensen ME Dan Med Bull; 1998 Apr; 45(2):121-34. PubMed ID: 9587699 [TBL] [Abstract][Full Text] [Related]
6. Clinical significance of Anoctamin-1 gene at 11q13 in the development and progression of head and neck squamous cell carcinomas. Rodrigo JP; Menéndez ST; Hermida-Prado F; Álvarez-Teijeiro S; Villaronga MÁ; Alonso-Durán L; Vallina A; Martínez-Camblor P; Astudillo A; Suárez C; María García-Pedrero J Sci Rep; 2015 Oct; 5():15698. PubMed ID: 26498851 [TBL] [Abstract][Full Text] [Related]
7. CD44s and CD44v6 expression in head and neck epithelia. Mack B; Gires O PLoS One; 2008; 3(10):e3360. PubMed ID: 18852874 [TBL] [Abstract][Full Text] [Related]
8. ANO1/TMEM16A interacts with EGFR and correlates with sensitivity to EGFR-targeting therapy in head and neck cancer. Bill A; Gutierrez A; Kulkarni S; Kemp C; Bonenfant D; Voshol H; Duvvuri U; Gaither LA Oncotarget; 2015 Apr; 6(11):9173-88. PubMed ID: 25823819 [TBL] [Abstract][Full Text] [Related]
9. Expression of Epithelial-Mesenchymal Transition Regulating Transcription Factors in Head and Neck Squamous Cell Carcinomas. Göppel J; Möckelmann N; Münscher A; Sauter G; Schumacher U Anticancer Res; 2017 Oct; 37(10):5435-5440. PubMed ID: 28982853 [TBL] [Abstract][Full Text] [Related]
10. Metallothionein immunoreactivity in head and neck carcinomas; special reference to clinical behaviors and chemotherapy responses. Muramatsu Y; Hasegawa Y; Fukano H; Ogawa T; Namuba M; Mouri K; Fujimoto Y; Matsuura H; Takai Y; Mori M Anticancer Res; 2000; 20(1A):257-64. PubMed ID: 10769664 [TBL] [Abstract][Full Text] [Related]
11. Dominant negative p63 isoform expression in head and neck squamous cell carcinoma. Sniezek JC; Matheny KE; Westfall MD; Pietenpol JA Laryngoscope; 2004 Dec; 114(12):2063-72. PubMed ID: 15564824 [TBL] [Abstract][Full Text] [Related]
12. Diagnostic role of DOG1 and p63 immunohistochemistry in salivary gland carcinomas. Abd Raboh NM; Hakim SA Int J Clin Exp Pathol; 2015; 8(8):9214-22. PubMed ID: 26464669 [TBL] [Abstract][Full Text] [Related]
13. Her2 expression and gene amplification is rarely detectable in patients with oral squamous cell carcinomas. Hanken H; Gaudin R; Gröbe A; Fraederich M; Eichhorn W; Smeets R; Simon R; Sauter G; Grupp K; Izbicki JR; Sehner S; Heiland M; Blessmann M J Oral Pathol Med; 2014 Apr; 43(4):304-8. PubMed ID: 24645976 [TBL] [Abstract][Full Text] [Related]
14. Expression and clinical significance of the Kv3.4 potassium channel subunit in the development and progression of head and neck squamous cell carcinomas. Menéndez ST; Rodrigo JP; Allonca E; García-Carracedo D; Alvarez-Alija G; Casado-Zapico S; Fresno MF; Rodríguez C; Suárez C; García-Pedrero JM J Pathol; 2010 Aug; 221(4):402-10. PubMed ID: 20593490 [TBL] [Abstract][Full Text] [Related]
15. Development of a programmed cell death ligand-1 immunohistochemical assay validated for analysis of non-small cell lung cancer and head and neck squamous cell carcinoma. Rebelatto MC; Midha A; Mistry A; Sabalos C; Schechter N; Li X; Jin X; Steele KE; Robbins PB; Blake-Haskins JA; Walker J Diagn Pathol; 2016 Oct; 11(1):95. PubMed ID: 27717372 [TBL] [Abstract][Full Text] [Related]
16. Is DOG1 Immunoreactivity Specific to Gastrointestinal Stromal Tumor? Swalchick W; Shamekh R; Bui MM Cancer Control; 2015 Oct; 22(4):498-504. PubMed ID: 26678977 [TBL] [Abstract][Full Text] [Related]
17. DOG1 antibody in the differential diagnosis of gastrointestinal stromal tumors: a study of 1840 cases. Miettinen M; Wang ZF; Lasota J Am J Surg Pathol; 2009 Sep; 33(9):1401-8. PubMed ID: 19606013 [TBL] [Abstract][Full Text] [Related]
18. In vivo optical imaging of folate receptor-β in head and neck squamous cell carcinoma. Sun JY; Shen J; Thibodeaux J; Huang G; Wang Y; Gao J; Low PS; Dimitrov DS; Sumer BD Laryngoscope; 2014 Aug; 124(8):E312-9. PubMed ID: 24448885 [TBL] [Abstract][Full Text] [Related]
19. DOG1 expression is common in human tumors: A tissue microarray study on more than 15,000 tissue samples. Jansen K; Farahi N; Büscheck F; Lennartz M; Luebke AM; Burandt E; Menz A; Kluth M; Hube-Magg C; Hinsch A; Höflmayer D; Weidemann S; Fraune C; Möller K; Lebok P; Sauter G; Simon R; Uhlig R; Wilczak W; Jacobsen F; Minner S; Krech R; Clauditz T; Bernreuther C; Dum D; Krech T; Marx A; Steurer S Pathol Res Pract; 2021 Dec; 228():153663. PubMed ID: 34717148 [TBL] [Abstract][Full Text] [Related]
20. Immunodetection of GLUT1, p63 and phospho-histone H1 in invasive head and neck squamous carcinoma: correlation of immunohistochemical staining patterns with keratinization. Burstein DE; Nagi C; Kohtz DS; Lee L; Wang B Histopathology; 2006 May; 48(6):717-22. PubMed ID: 16681688 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]